- Home
- KLAR vs BRKR Comparison
KLAR vs BRKR Comparison
Compare KLAR & BRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KLAR | BRKR |
|---|---|---|
| Founded | 2005 | 1960 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.7B | 8.6B |
| IPO Year | 2023 | 2000 |
Fundamental Metrics
Financial Performance| Metric | KLAR | BRKR |
|---|---|---|
| Price | $13.32 | $57.11 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 25 | 13 |
| Target Price | $19.29 | ★ $63.83 |
| AVG Volume (30 Days) | ★ 4.9M | 2.1M |
| Earning Date | 11-17-2026 | 11-04-2026 |
| Dividend Yield | N/A | ★ 0.32% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,895,600,000.00 |
| Revenue This Year | $17.72 | $3.48 |
| Revenue Next Year | $14.94 | $4.16 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $12.06 | $32.37 |
| 52 Week High | $38.19 | $66.45 |
Technical Indicators
Market Signals| Indicator | KLAR | BRKR |
|---|---|---|
| Relative Strength Index (RSI) | 49.19 | 45.08 |
| Support Level | $12.28 | $53.89 |
| Resistance Level | $15.22 | $63.33 |
| Average True Range (ATR) | 0.50 | 2.80 |
| MACD | 0.09 | 0.23 |
| Stochastic Oscillator | 59.15 | 27.23 |
Price Performance
Historical ComparisonAbout KLAR Klarna Group plc Ordinary Shares
Klarna Group PLC is a technology-driven payments company, with operations spanning multiple countries. It connects consumers and merchants with comprehensive payment solutions and tailored advertising solutions, both online and offline. Its payment solutions provide consumers with more control and flexibility over their payments. It is a digital bank and flexible payments provider building the next-generation AI-powered commerce network.
About BRKR Bruker Corporation
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies (BEST) . The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.